# NAD+ precursors and liver tests: start with the ingredient

Liver monitoring depends on the specific ingredient and clinical context. High-dose nicotinic acid risks should not be assigned to every NAD+ precursor.

Canonical: https://velri.co/blog/nad-precursors-liver-markers-road-warrior-before-starting
Publisher: Velri (https://velri.co/about)
Published: 2026-07-15
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

The phrase “NAD+ precursor” does not identify one product or one safety profile. Before deciding whether liver tests are relevant, the exact ingredient and formulation need to be clear. [1]

Nicotinic acid, a form of niacin, has well-described liver risks at high supplemental amounts. Other NAD-related compounds need their own safety assessment. [1]

## What is established for nicotinic acid?

The NIH Office of Dietary Supplements describes liver toxicity with high-dose nicotinic acid used over months or years. Reported effects include elevated liver enzymes and, in severe cases, liver injury. Extended-release forms carry particular concern. [1]

The fact sheet discusses clinical monitoring of liver enzymes in that context. It is not a universal screening protocol for every product marketed for cellular energy. [1]

## What do the liver measurements mean?

A comprehensive metabolic panel includes ALT, AST, alkaline phosphatase, bilirubin and albumin. These contribute different information to liver assessment and are interpreted with the rest of the panel, health history and medicines. [2]

An abnormal enzyme result usually creates a question about its cause. It does not identify a supplement as the cause without a timeline and broader evaluation. [2][3]

## What about newer precursors?

A small randomized trial of oral nicotinamide riboside found it was well tolerated during the study and increased NAD+ metabolism. Its short duration and selected participants limit what it can establish about long-term use or people with existing liver disease. [4]

Bring the exact label, other supplements, medicines and any previous liver results to the discussion. The useful answer explains whether testing is indicated for that ingredient and your circumstances, what a result would change, and what follow-up would mean.

## Sources
[1] Niacin - Health Professional Fact Sheet (2025). https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/?uid=f4727f1be0442s16
[2] Comprehensive Metabolic Panel (CMP): MedlinePlus Medical Test (2023). https://medlineplus.gov/lab-tests/comprehensive-metabolic-panel-cmp/
[3] How to Understand Your Lab Results: MedlinePlus Medical Test (2026). https://medlineplus.gov/lab-tests/how-to-understand-your-lab-results/
[4] Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876407/

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support